Table 1.
Drug Concentration (nM)* | Peak Fluid Volume (K) | Rate of Fluid Reabsorption (ka) | Rate of Fluid Secretion (ks) | Rate of Elimination of Drug (ke) |
---|---|---|---|---|
0 | −1.12 ± 0.399† | 0.0462 ± 0.0375 | 0.0060 ± 0.0024 | |
100 Carbachol | 2.05 ± 0.103† | 0.0239 ± 0.0178 | 85.6 ± 76.9 | 0.0060 ± 0.0027 |
250 Carbachol | 2.65 ± 0.104† | 0.0231 ± 0.00560 | 106. ± 26.4 | 0.0020 ± 0.0017 |
500 Carbachol | 3.22 ± 0.323† | 0.0316 ± 0.0108 | 102. ± 38.6 | 0.00040 ± 0.00090 |
500 Carbachol +500 Atropine | 2.66 ± 0.196‡ | 0.0119 ± 0.00230 | 223 ± 46.2 | 0.00040 ± 0.00090 |
Values are means ± SE. The model provides values for the peak amount of lung fluid, the initial rate of fluid absorption, and the rate at which fluid levels return to normal (i.e., the rate of drug elimination). The maximal effect of any of the treatments (K) can be statistically compared to measure the effect of different doses of carbachol.
Concentration in 0.1 ml of saline injected intraperitoneally,
All of these values are significantly different from one another (P < 0.05).
Peak fluid volume for 500 nM atropine +500 nM carbachol is significantly less than for 500 nM carbachol alone.